Photo of Meng Zhao, MD, PhD

Meng Zhao, MD, PhD

Accepting New Patients
1717 13th Street, Suite 300
Everett, WA 98201
2004.3 miles away
Speaks: Chinese - Mandarin and English
map

The Everett Clinic - Providence Regional Cancer Partnership

1717 13th Street, Suite 300, Everett, WA 98201

About Meng Zhao

Meng Zhao, MD, PhD, joined Providence Regional Cancer Partnership in July 2020. She received her medical degree from the Tongji University School of Medicine in Shanghai, China. Dr. Zhao completed an Internal Medicine Residency at the University of Texas Southwestern Medical Center, and then went on to study Oncology and Hematology at The Ohio State University Comprehensive Cancer Center and Wexner Medical Center in Columbus, OH. She is board certified by the American Board of Internal Medicine, the American Board of Medical Oncology, and the American Board of Hematology. She is also a member of the American Society of Clinical Oncology. She earned a PhD in Cell and Molecular Biology at the University of Texas at Austin in Austin, TX. Philosophy of Care: I provide my patients with comfort and confidence, along with high quality care. I am committed to providing personalized care, a shared decision-making practice model to guide open dialogues about diagnoses and treatment options with my patients and their families. I provide the latest treatments for all types of cancer and have a special interest in breast cancer, gastrointestinal cancer, lung cancer and hematological malignancies.

Professional Associations

American Society of Clinical Oncology

Board Certifications
  • American Board of Internal Medicine, Medical Oncology
  • American Board of Internal Medicine, Hematology

Spending time with family, traveling, and hiking.

Clinical Interests

  • Adverse Effects To Anticoagulants
  • Anemia
  • Bleeding Disorder
  • Blood Cancer
  • Blood Disorders
  • Bone Marrow Disorders
  • Breast Cancer
  • Breast Cancer Genomics
  • Cancer
  • Cancer Chemotherapy
  • Cancer Pain
  • Cancer Related Fatigue
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoma Of Unknown Primary
  • Chemoradiation
  • Colorectal Cancer
  • Crizotinib
  • Egfr Mutation
  • Egfr Translocation
  • Endocrine Complications Of Cancer Therapy
  • Endometrial Cancer
  • Erlotinib
  • Giant Cell Tumor Of The Bone
  • Gynecologic Cancer Genomics
  • Head And Neck Cancer
  • Hellp Syndrome
  • Hematologic Malignancies
  • Hemoglobinopathies
  • Idiopathic Thrombocytopenic Purpura
  • Iron Deficiency Anemia
  • Leukocytosis
  • Leukopenia
  • Lung Cancer
  • Lymphedema Therapy
  • Lymphoma
  • Lymphopenia
  • Melanoma
  • Metastatic Liver Cancer
  • Metastatic Prostate Cancer
  • Musculoskeletal Tumor
  • Myelodysplasia
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Neutropenia
  • Non Hodgkin Lymphoma
  • Oral Complications Of Cancer
  • Osteosarcoma
  • Pancytopenia
  • Petechiae
  • Polycythemia
  • Pulmonary Metastases
  • Retroperitoneal Mass
  • Sarcoma
  • Secondary Polycythemia
  • Side Effects Of Cancer Treatment
  • Splenomegaly
  • Stomach Cancer
  • Submucosal Tumors
  • Sweat Gland Carcinoma
  • Thalassemia
  • Thrombocytopenia
  • Thrombophilia
  • Thrombotic Thrombocytopenic Purpura
  • Thyroid Cancer
  • Tracheal Cancer
  • Unknown Primary Cancer
  • Von Willebrand Disease
  • Waldenstrom Macroglobulinemia